Niagen Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	66.55	64.79	44.66	27.33	20.44	28.22
Cash & Short-Term Investments	66.55	64.79	44.66	27.33	20.44	28.22
Cash Growth	19.66%	45.07%	63.44%	33.68%	-27.56%	69.01%
Accounts Receivable	13.07	9.74	7.77	5.23	8.48	5.23
Inventory	24.02	20.42	9.19	14.53	14.68	13.6
Other Current Assets	1.49	1.85	2.48	2.45	2.97	1.86
Total Current Assets	105.12	96.81	64.1	49.53	46.57	48.91
Net Property, Plant & Equipment	3.32	3.52	3.45	4.54	6.32	7.36
Other Intangible Assets	5.49	5.66	0.36	0.51	0.67	0.86
Other Long-Term Assets	0.41	0.43	0.37	0.38	0.5	0.72
Total Assets	114.33	106.41	68.28	54.96	54.06	57.84
Accounts Payable	13.28	10.8	8.53	10.23	9.68	10.42
Accrued Expenses	7.62	7.72	7.82	9.49	7.34	6.48
Current Portion of Leases	1.03	1	0.99	0.7	0.7	0.55
Unearned Revenue	0.38	0.4	0.61	0.2	0.16	0.16
Other Current Liabilities	0.51	-	-	-	-	-
Total Current Liabilities	22.82	19.92	17.95	20.62	17.87	17.61
Long-Term Leases	1.54	1.82	1.66	2.58	3.56	4.15
Other Long-Term Liabilities	7.63	8.14	2.58	3.31	3.96	4.35
Total Long-Term Liabilities	9.18	9.95	4.24	5.89	7.52	8.5
Total Liabilities	32	29.87	22.18	26.51	25.39	26.11
Common Stock	0.08	0.08	0.08	0.08	0.07	0.07
Additional Paid-in Capital	240.46	240.99	227.93	218.85	214.09	200.61
Accumulated Other Comprehensive Income	-0	-0.01	-0	-0	-0	-0
Retained Earnings	-158.21	-164.53	-181.91	-190.46	-185.49	-168.95
Shareholders' Equity	82.33	76.53	46.09	28.46	28.67	31.73
Total Liabilities & Equity	114.33	106.41	68.28	54.96	54.06	57.84
Total Debt	2.58	2.82	2.65	3.28	4.26	4.7
Net Cash (Debt)	63.97	61.97	42.01	24.05	16.18	23.52
Net Cash Growth	3.23%	47.52%	74.69%	48.59%	-31.18%	56.16%
Net Cash Per Share	0.75	0.72	0.54	0.32	0.23	0.35
Book Value	82.33	76.53	46.09	28.46	28.67	31.73
Book Value Per Share	0.96	0.90	0.59	0.38	0.41	0.47
Tangible Book Value	76.85	70.87	45.74	27.95	28	30.87
Tangible Book Value Per Share	0.90	0.83	0.59	0.37	0.40	0.46

SEC Filings: 10-K · 10-Q